Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-25

FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for ACANYA, a combination of clindamycin phosphate and benzoyl peroxide, manufactured by Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACANYA (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE)

Snippet

SUPPL AP for ACANYA (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE)